Literature DB >> 17059509

Review article: from 1906 to 2006--a century of major evolution of understanding of gastro-oesophageal reflux disease.

J Dent1.   

Abstract

BACKGROUND: Our understanding of gastro-oesophageal reflux disease has undergone significant changes over the last century. AIM: To trace the rise in understanding of gastro-oesophageal reflux disease and highlight remaining areas of uncertainty.
METHODS: Literature review.
RESULTS: In 1906, Tileston published his observations on 'peptic ulcer of the oesophagus'. Winkelstein, in 1934, first correlated symptoms of heartburn with acid regurgitation and reflux oesophagitis. In 1946, Allison described hiatus hernia as a causal factor in the development of gastro-oesophageal reflux disease. In 1958, Bernstein and Baker showed a direct relationship between oesophageal acidification and heartburn in patients with gastro-oesophageal reflux disease, irrespective of endoscopic findings, leading to the recognition of non-erosive gastro-oesophageal reflux disease. In the 1980s, continuous recordings of the lower oesophageal sphincter showed that episodes of reflux were related to transient relaxations of lower oesophageal sphincter tone. There is now increasing recognition that gastro-oesophageal reflux disease arises from the interaction of several anatomical and physiological factors. A turning point in the medical treatment of gastro-oesophageal reflux disease came with the introduction of the first proton pump inhibitor, omeprazole, in 1989.
CONCLUSIONS: Future efforts need to identify the multifactorial interactions of gastro-oesophageal junction anatomy and physiology in patients with gastro-oesophageal reflux disease. Increased understanding of the disease will guide development of new therapies.

Entities:  

Mesh:

Year:  2006        PMID: 17059509     DOI: 10.1111/j.1365-2036.2006.03122.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  9 in total

1.  Long-term outcomes in pediatric-onset esophageal eosinophilia.

Authors:  Charles W DeBrosse; James P Franciosi; Eileen C King; Bridget K Buckmeier Butz; Allison B Greenberg; Margaret H Collins; J Pablo Abonia; Amal Assa'ad; Philip E Putnam; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2011-06-02       Impact factor: 10.793

Review 2.  Advances in the Diagnosis and Treatment of GERD: New Tricks for an Old Disease.

Authors:  Rishi D Naik; Lauren Evers; Michael F Vaezi
Journal:  Curr Treat Options Gastroenterol       Date:  2019-03

3.  Does impaired gallbladder function contribute to the development of Barrett's esophagus and esophageal adenocarcinoma?

Authors:  Ayman O Nassr; Syeda Nadia Shah Gilani; Mohammed Atie; Tariq Abdelhafiz; Val Connolly; Neil Hickey; Thomas Noel Walsh
Journal:  J Gastrointest Surg       Date:  2011-04-12       Impact factor: 3.452

Review 4.  The enteric nervous system and neurogastroenterology.

Authors:  John B Furness
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-03-06       Impact factor: 46.802

5.  Findings from a novel scintigraphic gastroesophageal reflux study in asymptomatic volunteers.

Authors:  Leticia Burton; Gregory Leighton Falk; John Beattie; Daniel Novakovic; Scott Simpson; Hans Van der Wall
Journal:  Am J Nucl Med Mol Imaging       Date:  2020-12-15

Review 6.  Gastroesophageal reflux disease and Barrett's esophagus.

Authors:  Dino Vaira; Luigi Gatta; Chiara Ricci; Valentina Castelli; Giulia Fiorini; Enkeleda Kajo; Alberto Lanzini
Journal:  Intern Emerg Med       Date:  2010-07-08       Impact factor: 3.397

Review 7.  Contemplating the future without Helicobacter pylori and the dire consequences hypothesis.

Authors:  David Y Graham; Yoshio Yamaoka; Hoda M Malaty
Journal:  Helicobacter       Date:  2007-11       Impact factor: 5.753

Review 8.  Clinical practice. Gastroesophageal reflux disease.

Authors:  Peter J Kahrilas
Journal:  N Engl J Med       Date:  2008-10-16       Impact factor: 91.245

9.  Comorbidities are frequent in patients with gastroesophageal reflux disease in a tertiary health care hospital.

Authors:  Joaquim Prado P Moraes-Filho; Tomás Navarro-Rodriguez; Jaime N Eisig; Ricardo C Barbuti; Decio Chinzon; Eamonn M M Quigley
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.